"","submission_name","submission_date","template_name","response_component","curation_date","cohort","age_min","age_max","age_units","number_subjects","tissue_type","tissue_type_term_id","response_component_original","response_behavior_type","response_behavior","comparison","baseline_time_event","time_point","time_point_units","exposure_material_id","additional_exposure_material","vaccine_year","adjuvant","route","scheduling","publication_reference_id","publication_date","publication_reference_url","signature_source","signature_source_url","comments","cell_ontology_id","proterm_and_extra","pro_ontology_id","fully_qualified_response_component","response_comp_orig_cnt","response_comp_cnt","subm_obs_id","uniq_obs_id","row_key","signature_file","target_pathogen_1","target_pathogen_2","target_pathogen_3"
"subject","","","","cell_subset","","","","","","","cell_subset","","","","","","","","","vaccine","","","","","","","","","","","","","","","","","","","","","","pathogen","pathogen","pathogen"
"evidence","label","label","label","","label","label","label","label","label","label","","label","label","label","label","label","label","label","label","","label","label","label","label","label","label","label","url","label","label","label","label","label","label","label","label","label","label","label","label","file","","",""
"role","background","background","background","cell_biomarker","background","observed","observed","observed","observed","observed","tissue","background","observed","background","measured","background","background","observed","observed","vaccine","background","background","background","background","background","background","background","reference","background","background","background","observed","observed","observed","observed","observed","observed","background","background","background","observed","pathogen","pathogen","pathogen"
"mime_type","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"numeric_units","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"display_text","submission name","submission_date","template_name","response component (cell subset)","curation date","Cohort - any characteristics of the population(s) studied, plus whether the result was taken from a subgroup of the broader cohort tested.","age min.","age max.","age units","number of subjects","tissue type","tissue cell ontology ID","response component (original curated cell type)","response behavior type","response behavior","comparison","baseline time","time point","time point units","exposure material","additional exposure material","vaccine year","adjuvant","route","scheduling","publication reference (PMID)","print publication date or posted date if not in print (YYYY-MM-DD or YYYY)","Gon√ßalves et al. (2019) Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccination. J Clin Invest. PMID: <a href = 'https://www.ncbi.nlm.nih.gov/pubmed/?term=30843873' target='_blank'>30843873</a>","signature source figure, table or text section","signature source url","comments and additional details","response component cell ontology ID","response component protein ontology and extra terms","response component marker protein ontology ID","response component (fully qualified)","response component (original) count","response component count","ID of observation within a publication (PMID) and for its submission type ","ID of observation within its submission type","row key","response component (cell types) file","target pathogen 1","target pathogen 2","target pathogen 3"
"","hipc_ctf_30843873_2","2019.03.08","hipc_ctf_30843873_2","CD8-positive, alpha-beta T cell","","","18","45","years","60","blood serum","UBERON:0001977","T cell responder TIV-specific CD8+ GRZ+","cell type frequency","up","S2 vs S1 as defined by hierarchical clustering of gene expression","time of vaccination (first dose)","21","days","VO:0004899","","2012","","","","30843873","2019","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486343/","Fig 3f","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486343/figure/F3/' target='_blank'>figure/F3</a>","Clusters S1 and S2 were defined based on hierarchical clustering of gene expression and were shown to be enriched with significantly different levels of influenza specific MN antibodies as well as vaccination routes for d21/d0.","CL:0000625","& GZMB+, TIV-specific","PR:000003499","CD8-positive, alpha-beta T cell & GZMB+, TIV-specific","1","1","2","122","30843873_2_122","hipc_ctf_sig_30843873_2.txt","influenza A virus (A/California/7/2009(H1N1))","influenza A virus (A/Victoria/361/2011(H3N2))","influenza B virus (B/Wisconsin/01/2010)"
